SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), which is focused on the development of immunotherapies and its novel therapy for tumor ablation, announced today that Dr. Michael Fons, Executive Director, Corporate Development, will discuss Inovio’s pipeline of immunotherapy products, including DNA vaccines, as well as related business opportunities in a presentation at the BIO Business Forum at BIO’s International Convention 2007, Wednesday, May 9th, at 11:45 a.m. EDT (8:45 a.m. PDT). The conference is being held at the Boston Exhibition & Convention Center in Boston, MA, May 6-9, 2007.
